North Jutland based Ilochip has entered a contract with UK's SELEX Sensors and Airborne Systems Ltd (SELEX S&AS), a subsidiary of the Italian defence industry group Finmeccanica, to further develop Ilochip's invention, a diagnostic micro-laboratory on a chip which can detect biological pathogens including warfare agents.
Jes Østergaard, managing director of Ilochip says: "We are joining forces to develop our invention, a small device the size of a mobile phone which can detect bacteria and virus in air in 30 minutes." The biochip is an integrated lab on chip (ILOC) which can perform procedures that normally take several hours to carry out.
Ilopchip expects to have a demonstration model ready in 12 months.
John Innes, head of capability for new business of SELEX S&AS says: "This programme demonstrates SELEX S&AS' commitment to develop new sensor systems capabilities through investment in partnerships with key technology specialists."
Ilochip is the new name for Thomsen Bioscience, which was founded on 1st September 2001 – just one week before 9/11 – with the aim of developing a biological warfare detection device based on intelligent biochips. Within days of the attack on the Twin Towers and the Pentagon, a development contract was signed with the Danish and Swedish Ministries of Defence to develop a biochip. The company is based in Norresundby in north Jutland.
The news was reported by national daily newspaper Jyllands-Posten.